Rajeev M. Shah - Net Worth and Insider Trading
Rajeev M. Shah Net Worth
The estimated net worth of Rajeev M. Shah is at least $525 Million dollars as of 2025-04-19. Rajeev M. Shah is the Director of Eidos Therapeutics Inc and owns about 2,162,671 shares of Eidos Therapeutics Inc (EIDX) stock worth over $264 Million. Rajeev M. Shah is the Director, 10% Owner of Ra Pharmaceuticals Inc and owns about 4,858,260 shares of Ra Pharmaceuticals Inc (RARX) stock worth over $233 Million. Rajeev M. Shah is also the Director, 10% Owner of KalVista Pharmaceuticals Inc and owns about 1,441,070 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $17 Million. Besides these, Rajeev M. Shah also holds Satsuma Pharmaceuticals Inc (STSA) , Black Diamond Therapeutics Inc (BDTX) , Kala Bio Inc (KALA) , Solid Biosciences Inc (SLDB) . Details can be seen in Rajeev M. Shah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rajeev M. Shah has not made any transactions after 2020-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rajeev M. Shah
Rajeev M. Shah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rajeev M. Shah owns 50 companies in total, including Vaxcyte Inc (PCVX) , Cardiff Oncology Inc (CRDF) , and PMV Pharmaceuticals Inc (PMVP) among others .
Click here to see the complete history of Rajeev M. Shah’s form 4 insider trades.
Insider Ownership Summary of Rajeev M. Shah
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCVX | Vaxcyte Inc | 2020-06-16 | 10 percent owner |
| CRDF | Cardiff Oncology Inc | 2020-09-30 | 10 percent owner |
| PMVP | PMV Pharmaceuticals Inc | 2020-09-24 | 10 percent owner |
 | | 2020-09-16 | 10 percent owner |
| | 2019-11-08 | director & 10 percent owner |
| | 2020-05-05 | 10 percent owner |
| | 2020-08-18 | 10 percent owner |
| | 2020-07-23 | 10 percent owner |
| | 2020-07-23 | 10 percent owner |
| | 2020-07-21 | 10 percent owner |
| | 2020-07-09 | 10 percent owner |
| | 2020-06-25 | 10 percent owner |
| | 2020-06-25 | 10 percent owner |
| | 2020-03-13 | director |
| | 2020-03-03 | 10 percent owner |
| | 2020-06-18 | 10 percent owner |
| | 2018-01-30 | director |
| | 2019-09-17 | director & 10 percent owner |
| | 2020-05-27 | director |
| | 2020-04-02 | director & 10 percent owner |
| | 2019-10-25 | 10 percent owner |
| | 2020-03-11 | 10 percent owner |
| | 2020-02-14 | 10 percent owner |
| | 2020-02-03 | director |
| | 2020-01-23 | 10 percent owner |
| | 2017-10-12 | director |
| | 2021-08-03 | 10 percent owner |
| | 2021-06-30 | director & 10 percent owner |
| | 2020-12-07 | 10 percent owner |
| | 2021-04-01 | 10 percent owner |
| | 2021-09-14 | director & 10 percent owner |
| | 2020-11-22 | 10 percent owner |
| | 2020-08-06 | 10 percent owner |
| | 2021-08-09 | director & 10 percent owner |
| | 2021-04-29 | director & 10 percent owner |
| | 2021-07-28 | director & 10 percent owner |
| | 2021-06-29 | director & 10 percent owner |
| | 2021-06-23 | director |
| | 2021-02-04 | director & 10 percent owner |
| | 2021-06-10 | director & 10 percent owner |
| | 2021-07-22 | director |
| | 2022-05-05 | director & 10 percent owner |
| | 2021-09-14 | director & 10 percent owner |
| | 2022-03-24 | 10 percent owner |
| | 2022-08-16 | 10 percent owner |
| | 2022-11-08 | director |
| | 2022-11-09 | director & 10 percent owner |
| | 2022-11-08 | director |
| | 2020-03-11 | 10 percent owner |
| | 2023-02-09 | director & 10 percent owner |
Rajeev M. Shah Latest Holdings Summary
Rajeev M. Shah currently owns a total of 7 stocks. Among these stocks, Rajeev M. Shah owns 2,162,671 shares of Eidos Therapeutics Inc (EIDX) as of June 22, 2018, with a value of $264 Million and a weighting of 50.36%. Rajeev M. Shah owns 4,858,260 shares of Ra Pharmaceuticals Inc (RARX) as of December 14, 2018, with a value of $233 Million and a weighting of 44.42%. Rajeev M. Shah also owns 1,441,070 shares of KalVista Pharmaceuticals Inc (KALV) as of October 12, 2017, with a value of $17 Million and a weighting of 3.29%. The other 4 stocks Satsuma Pharmaceuticals Inc (STSA) , Black Diamond Therapeutics Inc (BDTX) , Kala Bio Inc (KALA) , Solid Biosciences Inc (SLDB) have a combined weighting of 1.92% among all his current holdings.
Latest Holdings of Rajeev M. Shah
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIDX | Eidos Therapeutics Inc | 2018-06-22 | 2,162,671 | 122.21 | 264,300,023 |
| RARX | Ra Pharmaceuticals Inc | 2018-12-14 | 4,858,260 | 47.99 | 233,147,897 |
| KALV | KalVista Pharmaceuticals Inc | 2017-10-12 | 1,441,070 | 12.00 | 17,292,840 |
| STSA | Satsuma Pharmaceuticals Inc | 2019-09-17 | 4,681,858 | 1.10 | 5,150,044 |
| BDTX | Black Diamond Therapeutics Inc | 2020-02-03 | 2,589,904 | 1.44 | 3,729,462 |
| KALA | Kala Bio Inc | 2020-03-13 | 217,492 | 3.46 | 751,435 |
| SLDB | Solid Biosciences Inc | 2018-01-30 | 179,296 | 2.55 | 457,205 |
Holding Weightings of Rajeev M. Shah
Rajeev M. Shah Form 4 Trading Tracker
According to the SEC Form 4 filings, Rajeev M. Shah has made a total of 0 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years. The most-recent trade in Eidos Therapeutics Inc is the acquisition of 1,058,824 shares on June 22, 2018, which cost Rajeev M. Shah around $18 Million.
According to the SEC Form 4 filings, Rajeev M. Shah has made a total of 0 transactions in Ra Pharmaceuticals Inc (RARX) over the past 5 years. The most-recent trade in Ra Pharmaceuticals Inc is the acquisition of 1,006,452 shares on December 14, 2018, which cost Rajeev M. Shah around $16 Million.
According to the SEC Form 4 filings, Rajeev M. Shah has made a total of 0 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years. The most-recent trade in KalVista Pharmaceuticals Inc is the acquisition of 850,000 shares on October 12, 2017, which cost Rajeev M. Shah around $7 Million.
More details on Rajeev M. Shah's insider transactions can be found in the Insider Trading History of Rajeev M. Shah table.Insider Trading History of Rajeev M. Shah
- 1
Rajeev M. Shah Trading Performance
GuruFocus tracks the stock performance after each of Rajeev M. Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rajeev M. Shah is 3.63%. GuruFocus also compares Rajeev M. Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rajeev M. Shah within 3 months outperforms 5 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rajeev M. Shah's insider trading performs compared to the benchmark.
Performance of Rajeev M. Shah
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.66 | | | | | |
| Relative Return to S&P 500(%) | 11.72 | | | | | |
Rajeev M. Shah Ownership Network
Ownership Network List of Rajeev M. Shah
Ownership Network Relation of Rajeev M. Shah
Rajeev M. Shah Owned Company Details
What does Vaxcyte Inc do?
Who are the key executives at Vaxcyte Inc?
Rajeev M. Shah is the 10 percent owner of Vaxcyte Inc. Other key executives at Vaxcyte Inc include SVP & Gen Counsel & Corp Sec Mikhail Eydelman , Chief Operating Officer Jim Wassil , and CFO & CBO Andrew Guggenhime .
Vaxcyte Inc (PCVX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 267,762 shares made by Grant Pickering , a net sale of 176,000 shares made by Andrew Guggenhime , and a net sale of 92,000 shares made by Jim Wassil .
In summary, during the past 3 months, insiders sold 42,000 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 42,000 shares. During the past 18 months, 659,309 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 659,309 shares.
Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vaxcyte Inc Insider Transactions
- Download to Excel(.xls)
What does Cardiff Oncology Inc do?
Who are the key executives at Cardiff Oncology Inc?
Rajeev M. Shah is the 10 percent owner of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Financial Officer James E. Levine , Chief Medical Officer Fairooz Kabbinavar , and Chief Scientific Officer Mark Erlander .
Cardiff Oncology Inc (CRDF) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 414,565 shares made by Gary W Pace , a net purchase of 10,000 shares made by Renee P Tannenbaum , and a net purchase of 7,716 shares made by James E. Levine .
In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 432,281 shares were bought by its insiders, resulting in a net purchase of 432,281 shares.
Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiff Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does PMV Pharmaceuticals Inc do?
Who are the key executives at PMV Pharmaceuticals Inc?
Rajeev M. Shah is the 10 percent owner of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include SVP & Regulatory Affairs and QA Deepika Jalota , 10 percent owner Orbimed Advisors Llc , and Chief Medical Officer Leila Alland .
PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 87,786 shares made by Orbimed Advisors Llc , a net sale of 7,218 shares made by Deepika Jalota , and a net sale of 2,891 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 97,895 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 97,895 shares.
PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.
PMV Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Richard William Scalzo , See Remarks Oxana Beskrovnaya , and director & 10 percent owner Dirk Kersten .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 852,067 shares made by Dirk Kersten , a net sale of 281,460 shares made by Richard William Scalzo , and a net sale of 146,044 shares made by Oxana Beskrovnaya .
In summary, during the past 3 months, insiders sold 12,786 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 12,786 shares. During the past 18 months, 8,012,855 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,266,570 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does 89bio Inc do?
Who are the key executives at 89bio Inc?
Rajeev M. Shah is the director & 10 percent owner of 89bio Inc. Other key executives at 89bio Inc include See Remarks Quoc Le-nguyen , director & 10 percent owner Ra Capital Healthcare Fund Lp , and director & Chief Executive Officer Rohan Palekar .
89bio Inc (ETNB) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in 89bio Inc (ETNB). Other recent insider transactions involving 89bio Inc (ETNB) include a net sale of 42,195 shares made by Rohan Palekar , a net sale of 54,247 shares made by Quoc Le-nguyen , and a net purchase of 7,064,285 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 15,329 shares of 89bio Inc (ETNB) in total and bought 5,729,285 shares, with a net purchase of 5,713,956 shares. During the past 18 months, 111,442 shares of 89bio Inc (ETNB) were sold and 7,104,285 shares were bought by its insiders, resulting in a net purchase of 6,992,843 shares.
89bio Inc (ETNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
89bio Inc Insider Transactions
- Download to Excel(.xls)
What does TG Therapeutics Inc do?
Who are the key executives at TG Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of TG Therapeutics Inc. Other key executives at TG Therapeutics Inc include CFO & Secretary and Treasurer Sean A Power , director & CEO and President Michael S Weiss , and 10 percent owner Ra Capital Management, L.p. .
TG Therapeutics Inc (TGTX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in TG Therapeutics Inc (TGTX). Other recent insider transactions involving TG Therapeutics Inc (TGTX) include a net sale of 64,500 shares made by Laurence N Charney , a net sale of 35,933 shares made by Sagar Lonial , and a net sale of 69,225 shares made by Sean A Power .
In summary, during the past 3 months, insiders sold 0 shares of TG Therapeutics Inc (TGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 189,658 shares of TG Therapeutics Inc (TGTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 189,658 shares.
TG Therapeutics Inc (TGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TG Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Inhibrx Inc do?
Who are the key executives at Inhibrx Inc?
Rajeev M. Shah is the 10 percent owner of Inhibrx Inc. Other key executives at Inhibrx Inc include director & 10 percent owner & Chief Scientific Officer Brendan P. Eckelman , 10 percent owner Ole Andreas Halvorsen , and 10 percent owner Viking Global Opportunities Parent Gp Llc .
Inhibrx Inc (INBX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Inhibrx Inc (INBX). Other recent insider transactions involving Inhibrx Inc (INBX) include a net sale of 300,000 shares made by Brendan P. Eckelman ,
In summary, during the past 3 months, insiders sold 0 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300,000 shares of Inhibrx Inc (INBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 300,000 shares.
Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibrx Inc Insider Transactions
- Download to Excel(.xls)
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Rajeev M. Shah is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and 10 percent owner Longitude Capital Partners Iii, Llc .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net sale of 16,342 shares made by Douglas A Treco ,
In summary, during the past 3 months, insiders sold 8,819 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 8,819 shares. During the past 18 months, 16,342 shares of Inozyme Pharma Inc (INZY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,342 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does ITeos Therapeutics Inc do?
Who are the key executives at ITeos Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of ITeos Therapeutics Inc. Other key executives at ITeos Therapeutics Inc include Chief Financial Officer Matthew Gall , other: See remarks Joseph Lewis , and other: See remarks Boxer Asset Management Inc. .
ITeos Therapeutics Inc (ITOS) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in ITeos Therapeutics Inc (ITOS). Other recent insider transactions involving ITeos Therapeutics Inc (ITOS) include a net purchase of 5,000 shares made by Matthew Gall ,
In summary, during the past 3 months, insiders sold 0 shares of ITeos Therapeutics Inc (ITOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ITeos Therapeutics Inc (ITOS) were sold and 5,000 shares were bought by its insiders, resulting in a net purchase of 5,000 shares.
ITeos Therapeutics Inc (ITOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
ITeos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Mva Investors, Llc , and 10 percent owner Polaris Partners VIII, L.P. .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Rajeev M. Shah is the 10 percent owner of Nkarta Inc. Other key executives at Nkarta Inc include See Remarks Alyssa Levin , Chief Medical Officer David Shook , and Chief Legal Officer Alicia J. Hager .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 18,261 shares made by Alicia J. Hager , a net sale of 28,845 shares made by Paul J Hastings , and a net sale of 12,646 shares made by David Shook .
In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 84,937 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,915,063 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
- Download to Excel(.xls)
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Rajeev M. Shah is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , EVP & Head of International Yann Mazabraud , and Corporate Controller & CAO Christopher Paul German .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 188,715 shares made by Joseph Shulman , a net sale of 141,432 shares made by Jennifer Chien , and a net sale of 107,577 shares made by Pamela J. Cramer .
In summary, during the past 3 months, insiders sold 155,744 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 155,744 shares. During the past 18 months, 807,890 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 807,890 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Akouos Inc do?
Who are the key executives at Akouos Inc?
Rajeev M. Shah is the 10 percent owner of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .
Akouos Inc (AKUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akouos Inc Insider Transactions
- Download to Excel(.xls)
What does Kala Bio Inc do?
Who are the key executives at Kala Bio Inc?
Rajeev M. Shah is the director of Kala Bio Inc. Other key executives at Kala Bio Inc include CHIEF BUSINESS OFFICER Darius Kharabi , director & Chief Executive Officer Mark T Iwicki , and Chief Financial Officer Mary Reumuth .
Kala Bio Inc (KALA) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Kala Bio Inc (KALA). Other recent insider transactions involving Kala Bio Inc (KALA) include a net sale of 32,878 shares made by Mark T Iwicki , a net sale of 11,554 shares made by Romulus K Brazzell , and a net sale of 10,144 shares made by Todd Bazemore .
In summary, during the past 3 months, insiders sold 0 shares of Kala Bio Inc (KALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 73,480 shares of Kala Bio Inc (KALA) were sold and 310,559 shares were bought by its insiders, resulting in a net purchase of 237,079 shares.
Kala Bio Inc (KALA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kala Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Verastem Inc do?
Who are the key executives at Verastem Inc?
Rajeev M. Shah is the 10 percent owner of Verastem Inc. Other key executives at Verastem Inc include Vice President of Finance Daniel Calkins , Chief Operating Officer Dan Paterson , and Chief Financial Officer Robert E. Gagnon .
Verastem Inc (VSTM) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 565 shares made by Daniel Calkins , a net sale of 15,864 shares made by Dan Paterson , and a net sale of 20,766 shares made by Robert E. Gagnon .
In summary, during the past 3 months, insiders sold 2,070 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 2,070 shares. During the past 18 months, 42,152 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,152 shares.
Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verastem Inc Insider Transactions
- Download to Excel(.xls)
What does Forma Therapeutics Holdings Inc do?
Who are the key executives at Forma Therapeutics Holdings Inc?
Rajeev M. Shah is the 10 percent owner of Forma Therapeutics Holdings Inc. Other key executives at Forma Therapeutics Holdings Inc include EVP & Research & Development Agustin Melian , SVP & Chief Scientific Officer David N Cook , and SVP & Chief Financial Officer Todd Shegog .
Forma Therapeutics Holdings Inc (FMTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Forma Therapeutics Holdings Inc (FMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forma Therapeutics Holdings Inc (FMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Forma Therapeutics Holdings Inc (FMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Forma Therapeutics Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Solid Biosciences Inc do?
Who are the key executives at Solid Biosciences Inc?
Rajeev M. Shah is the director of Solid Biosciences Inc. Other key executives at Solid Biosciences Inc include director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , 10 percent owner Bain Capital Life Sciences Investors, Llc , and Chief Medical Officer Gabriel Brooks .
Solid Biosciences Inc (SLDB) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 4,654 shares made by Ilan Ganot , a net sale of 16,000 shares made by David T Howton , and a net sale of 12,568 shares made by Jessie Hanrahan .
In summary, during the past 3 months, insiders sold 30,968 shares of Solid Biosciences Inc (SLDB) in total and bought 6,254,405 shares, with a net purchase of 6,223,437 shares. During the past 18 months, 86,375 shares of Solid Biosciences Inc (SLDB) were sold and 10,570,378 shares were bought by its insiders, resulting in a net purchase of 10,484,003 shares.
Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Solid Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Satsuma Pharmaceuticals Inc do?
Who are the key executives at Satsuma Pharmaceuticals Inc?
Rajeev M. Shah is the director & 10 percent owner of Satsuma Pharmaceuticals Inc. Other key executives at Satsuma Pharmaceuticals Inc include 10 percent owner Shin Nippon Biomedical Laboratories, Ltd. , director & 10 percent owner Ken Takanashi , and 10 percent owner Braden Michael Leonard .
Satsuma Pharmaceuticals Inc (STSA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Satsuma Pharmaceuticals Inc (STSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Satsuma Pharmaceuticals Inc (STSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Satsuma Pharmaceuticals Inc (STSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Satsuma Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Eidos Therapeutics Inc do?
Who are the key executives at Eidos Therapeutics Inc?
Rajeev M. Shah is the director of Eidos Therapeutics Inc. Other key executives at Eidos Therapeutics Inc include director & Chief Scientific Officer Uma Sinha , Senior Vice President & Finance Franco Valle , and Chief Business Officer Cameron Turtle .
Eidos Therapeutics Inc (EIDX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eidos Therapeutics Inc (EIDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eidos Therapeutics Inc (EIDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eidos Therapeutics Inc (EIDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eidos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Ra Pharmaceuticals Inc do?
Who are the key executives at Ra Pharmaceuticals Inc?
Rajeev M. Shah is the director & 10 percent owner of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & President and CEO Douglas A Treco , and 10 percent owner Scott D Sandell .
Ra Pharmaceuticals Inc (RARX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ra Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Phathom Pharmaceuticals Inc do?
Who are the key executives at Phathom Pharmaceuticals Inc?
Rajeev M. Shah is the 10 percent owner of Phathom Pharmaceuticals Inc. Other key executives at Phathom Pharmaceuticals Inc include CFO and CBO Molly Henderson , Chief Operating Officer Azmi Nabulsi , and 10 percent owner Takeda Pharmaceutical Co Ltd .
Phathom Pharmaceuticals Inc (PHAT) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Phathom Pharmaceuticals Inc (PHAT). Other recent insider transactions involving Phathom Pharmaceuticals Inc (PHAT) include a net sale of 40,238 shares made by Molly Henderson , a net sale of 69,808 shares made by Terrie Curran , and a net purchase of 27,500 shares made by Asit Parikh .
In summary, during the past 3 months, insiders sold 37,256 shares of Phathom Pharmaceuticals Inc (PHAT) in total and bought 10,000 shares, with a net sale of 27,256 shares. During the past 18 months, 3,833,654 shares of Phathom Pharmaceuticals Inc (PHAT) were sold and 40,000 shares were bought by its insiders, resulting in a net sale of 3,793,654 shares.
Phathom Pharmaceuticals Inc (PHAT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Phathom Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Imara Inc do?
Who are the key executives at Imara Inc?
Rajeev M. Shah is the 10 percent owner of Imara Inc. Other key executives at Imara Inc include director & President & CEO Rahul D. Ballal , See Remarks Michael Gray , and 10 percent owner Braden Michael Leonard .
Imara Inc (IMRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Imara Inc Insider Transactions
- Download to Excel(.xls)
What does scPharmaceuticals Inc do?
Who are the key executives at scPharmaceuticals Inc?
Rajeev M. Shah is the 10 percent owner of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .
scPharmaceuticals Inc (SCPH) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in scPharmaceuticals Inc (SCPH). Other recent insider transactions involving scPharmaceuticals Inc (SCPH) include a net purchase of 500,000 shares made by Orbimed Advisors Llc ,
In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 500,000 shares were bought by its insiders, resulting in a net purchase of 500,000 shares.
scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
scPharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Rajeev M. Shah is the director of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , 10 percent owner Versant Venture Capital Vi, L.p. , and director & 10 percent owner Ali Behbahani .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net sale of 5,784,292 shares made by Biotech Growth N V , and a net sale of 221,600 shares made by Versant Venture Capital Vi, L.p. .
In summary, during the past 3 months, insiders sold 5,784,292 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 5,784,292 shares. During the past 18 months, 6,005,892 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,005,892 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Synthorx Inc do?
Who are the key executives at Synthorx Inc?
Rajeev M. Shah is the 10 percent owner of Synthorx Inc. Other key executives at Synthorx Inc include 10 percent owner Ra Capital Healthcare Fund Lp , 10 percent owner Ra Capital Management, L.p. , and director & 10 percent owner Peter Kolchinsky .
Synthorx Inc (THOR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Synthorx Inc (THOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Synthorx Inc (THOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Synthorx Inc (THOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synthorx Inc Insider Transactions
- Download to Excel(.xls)
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Rajeev M. Shah is the director of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include 10 percent owner Venrock Healthcare Capital Partners Iii, L.p. , CFO and Secretary Benjamin L Palleiko , and Chief Medical Officer Paul K. Audhya .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,612,229 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 161,456 shares made by Benjamin L Palleiko , and a net sale of 93,354 shares made by Christopher Yea .
In summary, during the past 3 months, insiders sold 21,811 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 361,212 shares, with a net purchase of 339,401 shares. During the past 18 months, 563,712 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,612,229 shares were bought by its insiders, resulting in a net purchase of 1,048,517 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does RxSight Inc do?
Who are the key executives at RxSight Inc?
Rajeev M. Shah is the 10 percent owner of RxSight Inc. Other key executives at RxSight Inc include Chief Operating Officer Ilya Goldshleger , director & See Remarks Kurtz Ronald M Md , and Chief Financial Officer Shelley B Thunen .
RxSight Inc (RXST) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in RxSight Inc (RXST). Other recent insider transactions involving RxSight Inc (RXST) include a net sale of 166,861 shares made by Ilya Goldshleger , a net sale of 50,000 shares made by Eric Weinberg , and a net sale of 116,772 shares made by Shelley B Thunen .
In summary, during the past 3 months, insiders sold 10,519 shares of RxSight Inc (RXST) in total and bought 0 shares, with a net sale of 10,519 shares. During the past 18 months, 1,581,689 shares of RxSight Inc (RXST) were sold and 38,686 shares were bought by its insiders, resulting in a net sale of 1,543,003 shares.
RxSight Inc (RXST)'s detailed insider trading history can be found in Insider Trading Tracker table.
RxSight Inc Insider Transactions
- Download to Excel(.xls)
What does Acumen Pharmaceuticals Inc do?
Who are the key executives at Acumen Pharmaceuticals Inc?
Rajeev M. Shah is the director & 10 percent owner of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Financial Officer Matt Zuga , Chief Legal Office & Corp Sec Derek M Meisner , and director & President and CEO Daniel Joseph Oconnell .
Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Acumen Pharmaceuticals Inc (ABOS). Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net sale of 75,597 shares made by Daniel Joseph Oconnell , a net sale of 50,743 shares made by Matt Zuga , and a net sale of 23,473 shares made by Derek M Meisner .
In summary, during the past 3 months, insiders sold 55,436 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 55,436 shares. During the past 18 months, 180,398 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 180,398 shares.
Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acumen Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Viridian Therapeutics Inc do?
Who are the key executives at Viridian Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & President and CEO Stephen F. Mahoney , Chief Operating Officer Thomas W. Beetham , and director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc .
Viridian Therapeutics Inc (VRDN) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc , and a net purchase of 21,400 shares made by Stephen F. Mahoney .
In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,102,590 shares.
Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viridian Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does WAVE Life Sciences Ltd do?
Who are the key executives at WAVE Life Sciences Ltd?
Rajeev M. Shah is the 10 percent owner of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include director & See Remarks Paul Bolno , See Remarks Chris Francis , and 10 percent owner Plc Glaxosmithkline .
WAVE Life Sciences Ltd (WVE) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 409,099 shares made by Paul Bolno , a net purchase of 6,091,930 shares made by Plc Glaxosmithkline , and a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 179,525 shares of WAVE Life Sciences Ltd (WVE) in total and bought 0 shares, with a net sale of 179,525 shares. During the past 18 months, 697,211 shares of WAVE Life Sciences Ltd (WVE) were sold and 8,091,930 shares were bought by its insiders, resulting in a net purchase of 7,394,719 shares.
WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.
WAVE Life Sciences Ltd Insider Transactions
- Download to Excel(.xls)
What does DICE Therapeutics Inc do?
Who are the key executives at DICE Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of DICE Therapeutics Inc. Other key executives at DICE Therapeutics Inc include 10 percent owner Northpond Ventures Gp, Llc , CSO John R. Jacobsen , and director & CEO Kevin Judice .
DICE Therapeutics Inc (DICE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of DICE Therapeutics Inc (DICE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DICE Therapeutics Inc (DICE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
DICE Therapeutics Inc (DICE)'s detailed insider trading history can be found in Insider Trading Tracker table.
DICE Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Iterum Therapeutics PLC do?
Who are the key executives at Iterum Therapeutics PLC?
Rajeev M. Shah is the 10 percent owner of Iterum Therapeutics PLC. Other key executives at Iterum Therapeutics PLC include Chief Scientific Officer Michael W. Dunne , director & President & CEO Fishman Corey N. , and Chief Medical Officer Sailaja Puttagunta .
Iterum Therapeutics PLC (ITRM) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Iterum Therapeutics PLC (ITRM). Other recent insider transactions involving Iterum Therapeutics PLC (ITRM) include a net purchase of 55,000 shares made by Michael W. Dunne , and a net purchase of 10,000 shares made by Fishman Corey N. .
In summary, during the past 3 months, insiders sold 0 shares of Iterum Therapeutics PLC (ITRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iterum Therapeutics PLC (ITRM) were sold and 65,000 shares were bought by its insiders, resulting in a net purchase of 65,000 shares.
Iterum Therapeutics PLC (ITRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iterum Therapeutics PLC Insider Transactions
- Download to Excel(.xls)
What does Orchard Therapeutics PLC do?
Who are the key executives at Orchard Therapeutics PLC?
Rajeev M. Shah is the 10 percent owner of Orchard Therapeutics PLC. Other key executives at Orchard Therapeutics PLC include director & See Remarks Bobby Gaspar , 10 percent owner & other: See Remark 1 Fmr Llc , and 10 percent owner Ra Capital Healthcare Fund Lp .
Orchard Therapeutics PLC (ORTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Orchard Therapeutics PLC (ORTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orchard Therapeutics PLC (ORTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Orchard Therapeutics PLC (ORTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Orchard Therapeutics PLC Insider Transactions
- Download to Excel(.xls)
What does Climb Bio Inc do?
Who are the key executives at Climb Bio Inc?
Rajeev M. Shah is the director & 10 percent owner of Climb Bio Inc. Other key executives at Climb Bio Inc include Chief Accounting Officer Emily Pimblett , Chief Scientific Officer Valerie Morisset , and director & 10 percent owner Ra Capital Healthcare Fund Lp .
Climb Bio Inc (CLYM) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Climb Bio Inc (CLYM). Other recent insider transactions involving Climb Bio Inc (CLYM) include a net sale of 481,639 shares made by Valerie Morisset , a net sale of 4,870 shares made by Emily Pimblett , and a net purchase of 13,008,546 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 1,199 shares of Climb Bio Inc (CLYM) in total and bought 0 shares, with a net sale of 1,199 shares. During the past 18 months, 486,509 shares of Climb Bio Inc (CLYM) were sold and 13,008,546 shares were bought by its insiders, resulting in a net purchase of 12,522,037 shares.
Climb Bio Inc (CLYM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Climb Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Werewolf Therapeutics Inc do?
Who are the key executives at Werewolf Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Technology Officer Chulani Karunatilake , and Chief Operating Officer Reid Leonard .
Werewolf Therapeutics Inc (HOWL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc (HOWL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Werewolf Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Icosavax Inc do?
Who are the key executives at Icosavax Inc?
Rajeev M. Shah is the director & 10 percent owner of Icosavax Inc. Other key executives at Icosavax Inc include director & Chief Executive Officer Adam K. Simpson , Chief Medical Officer Niranjan Kanesa-thasan , and Chief Financial Officer Thomas Joseph Russo .
Icosavax Inc (ICVX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 182,205 shares made by Adam K. Simpson , a net sale of 16,693 shares made by Cassia Cearley , and a net sale of 15,183 shares made by Thomas Joseph Russo .
In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 225,965 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,965 shares.
Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Icosavax Inc Insider Transactions
- Download to Excel(.xls)
What does Aerovate Therapeutics Inc do?
Who are the key executives at Aerovate Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Aerovate Therapeutics Inc. Other key executives at Aerovate Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , See Remarks George A Eldridge , and SENIOR VICE PRESIDENT & CMC Marinus Verwijs .
Aerovate Therapeutics Inc (AVTE) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Aerovate Therapeutics Inc (AVTE). Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 63,100 shares made by Hunter Gillies , a net sale of 96,907 shares made by Benjamin T Dake , and a net sale of 64,995 shares made by George A Eldridge .
In summary, during the past 3 months, insiders sold 0 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 331,084 shares of Aerovate Therapeutics Inc (AVTE) were sold and 928,110 shares were bought by its insiders, resulting in a net purchase of 597,026 shares.
Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerovate Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does POINT Biopharma Global Inc do?
Who are the key executives at POINT Biopharma Global Inc?
Rajeev M. Shah is the director of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Gp Holdings Llc .
POINT Biopharma Global Inc (PNT) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in POINT Biopharma Global Inc (PNT). Other recent insider transactions involving POINT Biopharma Global Inc (PNT) include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P ,
In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc (PNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,161,278 shares.
POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
POINT Biopharma Global Inc Insider Transactions
- Download to Excel(.xls)
What does Vor Biopharma Inc do?
Who are the key executives at Vor Biopharma Inc?
Rajeev M. Shah is the director & 10 percent owner of Vor Biopharma Inc. Other key executives at Vor Biopharma Inc include Chief Medical Officer Eyal C. Attar , director & 10 percent owner Kush Parmar , and 10 percent owner 5am Ventures Vi, L.p. .
Vor Biopharma Inc (VOR) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Vor Biopharma Inc (VOR). Other recent insider transactions involving Vor Biopharma Inc (VOR) include a net sale of 29,760 shares made by Eyal C. Attar ,
In summary, during the past 3 months, insiders sold 4,781 shares of Vor Biopharma Inc (VOR) in total and bought 0 shares, with a net sale of 4,781 shares. During the past 18 months, 29,760 shares of Vor Biopharma Inc (VOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 29,760 shares.
Vor Biopharma Inc (VOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vor Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does Janux Therapeutics Inc do?
Who are the key executives at Janux Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Business Officer Andrew Hollman Meyer , and director & Chief Executive Officer David Alan Campbell .
Janux Therapeutics Inc (JANX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 3,324,326 shares made by Avalon Ventures Xi, L.p. , a net sale of 120,000 shares made by David Alan Campbell , and a net sale of 70,002 shares made by Andrew Hollman Meyer .
In summary, during the past 3 months, insiders sold 6,668 shares of Janux Therapeutics Inc (JANX) in total and bought 824,041 shares, with a net purchase of 817,373 shares. During the past 18 months, 6,695,718 shares of Janux Therapeutics Inc (JANX) were sold and 4,573,603 shares were bought by its insiders, resulting in a net sale of 2,122,115 shares.
Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Janux Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Cytek Biosciences Inc do?
Who are the key executives at Cytek Biosciences Inc?
Rajeev M. Shah is the director of Cytek Biosciences Inc. Other key executives at Cytek Biosciences Inc include director & Chief Technology Officer Ming Yan , Chief Financial Officer Patrick Jeanmonod , and director & President and CEO Wenbin Jiang .
Cytek Biosciences Inc (CTKB) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Cytek Biosciences Inc (CTKB). Other recent insider transactions involving Cytek Biosciences Inc (CTKB) include a net sale of 101,900 shares made by Ming Yan , a net sale of 9,000 shares made by Patrick Jeanmonod , and a net sale of 20,000 shares made by Wenbin Jiang .
In summary, during the past 3 months, insiders sold 0 shares of Cytek Biosciences Inc (CTKB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 130,900 shares of Cytek Biosciences Inc (CTKB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 130,900 shares.
Cytek Biosciences Inc (CTKB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytek Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does PepGen Inc do?
Who are the key executives at PepGen Inc?
Rajeev M. Shah is the director & 10 percent owner of PepGen Inc. Other key executives at PepGen Inc include director & President and CEO James G Mcarthur , Chief Financial Officer Noel Donnelly , and See Remarks Michelle L Mellion .
PepGen Inc (PEPG) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net sale of 50,000 shares made by Michelle L Mellion , a net purchase of 43,194 shares made by James G Mcarthur , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 2,959 shares of PepGen Inc (PEPG) in total and bought 41,500 shares, with a net purchase of 38,541 shares. During the past 18 months, 62,959 shares of PepGen Inc (PEPG) were sold and 2,600,787 shares were bought by its insiders, resulting in a net purchase of 2,537,828 shares.
PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.
PepGen Inc Insider Transactions
- Download to Excel(.xls)
What does Tyra Biosciences Inc do?
Who are the key executives at Tyra Biosciences Inc?
Rajeev M. Shah is the director & 10 percent owner of Tyra Biosciences Inc. Other key executives at Tyra Biosciences Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Financial Officer Alan Fuhrman , and director & Chief Executive Officer Todd Harris .
Tyra Biosciences Inc (TYRA) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Tyra Biosciences Inc (TYRA). Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 125,393 shares made by Daniel Bensen , a net sale of 265,401 shares made by Nina S Kjellson , and a net sale of 250,000 shares made by Todd Harris .
In summary, during the past 3 months, insiders sold 35,267 shares of Tyra Biosciences Inc (TYRA) in total and bought 0 shares, with a net sale of 35,267 shares. During the past 18 months, 640,794 shares of Tyra Biosciences Inc (TYRA) were sold and 1,230,181 shares were bought by its insiders, resulting in a net purchase of 589,387 shares.
Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tyra Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include Chief Development Officer Sanjay Chanda , Chief Financial Officer Lucy Day , and See Remarks Joshua M Eizen .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net purchase of 329,906 shares made by Robin Shane Readnour , a net sale of 73,000 shares made by Joseph S Zakrzewski , and a net sale of 101,810 shares made by Adjuvant Global Health Technology Fund De, L.p. .
In summary, during the past 3 months, insiders sold 0 shares of AN2 Therapeutics Inc (ANTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,864,191 shares of AN2 Therapeutics Inc (ANTX) were sold and 1,912,000 shares were bought by its insiders, resulting in a net sale of 1,952,191 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,120 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,120 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,240 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Rajeev M. Shah is the director of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and director & 10 percent owner & other: * Director by deputization Deerfield Management Company, L.p. (series C) .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Acrivon Therapeutics Inc do?
Who are the key executives at Acrivon Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Acrivon Therapeutics Inc. Other key executives at Acrivon Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Legal Officer Mary Miller , and director & President and CEO Peter Blume-jensen .
Acrivon Therapeutics Inc (ACRV) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Acrivon Therapeutics Inc (ACRV). Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net purchase of 2,353,000 shares made by Perceptive Life Sciences Master Fund Ltd ,
In summary, during the past 3 months, insiders sold 0 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acrivon Therapeutics Inc (ACRV) were sold and 2,353,000 shares were bought by its insiders, resulting in a net purchase of 2,353,000 shares.
Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acrivon Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ARS Pharmaceuticals Inc do?
Who are the key executives at ARS Pharmaceuticals Inc?
Rajeev M. Shah is the director of ARS Pharmaceuticals Inc. Other key executives at ARS Pharmaceuticals Inc include director & Chief Executive Officer Laura Shawver , Chief Commercial Officer Eric Karas , and 10 percent owner & Chief Medical Officer Sarina Tanimoto .
ARS Pharmaceuticals Inc (SPRY) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in ARS Pharmaceuticals Inc (SPRY). Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 2,003,260 shares made by Richard E Lowenthal , a net sale of 2,003,260 shares made by Sarina Tanimoto , and a net sale of 529,245 shares made by Justin Chakma .
In summary, during the past 3 months, insiders sold 160,002 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 0 shares, with a net sale of 160,002 shares. During the past 18 months, 7,588,791 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 1,401,299 shares were bought by its insiders, resulting in a net sale of 6,187,492 shares.
ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARS Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Enliven Therapeutics Inc do?
Who are the key executives at Enliven Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include Chief Operating Officer Anish Patel , Chief Financial Officer Benjamin Hohl , and director & Chief Scientific Officer Joseph P Lyssikatos .
Enliven Therapeutics Inc (ELVN) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 110,564 shares made by Benjamin Hohl , a net sale of 240,842 shares made by Samuel Kintz , and a net sale of 240,347 shares made by Joseph P Lyssikatos .
In summary, during the past 3 months, insiders sold 56,751 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 56,751 shares. During the past 18 months, 4,289,827 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,289,827 shares.
Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enliven Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Mineralys Therapeutics Inc do?
Who are the key executives at Mineralys Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Mineralys Therapeutics Inc. Other key executives at Mineralys Therapeutics Inc include Chief Medical Officer David Malcom Rodman , director & Chief Executive Officer Jon Congleton , and CFO & Chief Bus. Off. and Secy. Adam Scott Levy .
Mineralys Therapeutics Inc (MLYS) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Mineralys Therapeutics Inc (MLYS). Other recent insider transactions involving Mineralys Therapeutics Inc (MLYS) include a net sale of 182,529 shares made by Jon Congleton , a net sale of 98,270 shares made by David Malcom Rodman , and a net sale of 139,843 shares made by Adam Scott Levy .
In summary, during the past 3 months, insiders sold 93,213 shares of Mineralys Therapeutics Inc (MLYS) in total and bought 2,496,296 shares, with a net purchase of 2,403,083 shares. During the past 18 months, 974,892 shares of Mineralys Therapeutics Inc (MLYS) were sold and 3,056,101 shares were bought by its insiders, resulting in a net purchase of 2,081,209 shares.
Mineralys Therapeutics Inc (MLYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mineralys Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
Rajeev M. Shah Mailing Address
Above is the net worth, insider trading, and ownership report for Rajeev M. Shah. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Rajeev M. Shah's mailing address is: Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
